|
|
||||||||
,
,
,
,
,
Departments of
*
Medicine and
Pathology and Laboratory Medicine, and
Abramson Family Cancer Research Institute, University of Pennsylvania, and
Biesecker Pediatric Liver Center, Childrens Hospital of Philadelphia, Philadelphia, PA 19104
Toll-like receptors (TLR) initiate rapid innate immune responses by recognizing microbial products. These events in turn lead to the development of an efficient adaptive immune response through the up-regulation of a number of costimulatory molecules, including members of the TNF/TNFR superfamily, on the surface of an APC. TNFR-associated factor 6 (TRAF6) is a common signaling adapter used by members of both the TNFR and the TLR/IL-1R superfamilies, and as such plays a critical role in the development of immune responses. As TRAF6-deficient mice die prematurely, we generated chimeras reconstituted with TRAF6-deficient fetal liver cells to analyze functions of TRAF6 in vivo in the hemopoietic compartment. We found that TRAF6-deficient chimeras develop a progressive lethal inflammatory disease associated with massive organ infiltration and activation of CD4+ T cells in a Th2-polarized phenotype, and a defect in IL-18 responsiveness. When recombination-activating gene 2-/- blastocysts were complemented with TRAF6-deficient embryonic stem cells, a marked elevation of activated CD4+ T cells and progressive inflammatory disease were also observed. Moreover, T cell activation and lethal inflammation were not reversed in mixed chimeric mice generated from normal and TRAF6-deficient fetal liver cells. These results suggest that deletion of TRAF6 induces a dominant Th2-type polarized autoimmune response. Therefore, in addition to playing a critical role in innate and adaptive immunity, TRAF6 is likely to play a previously unrecognized role in the maintenance of self-tolerance.
This article has been cited by other articles:
![]() |
P. J. Bryce, M. K. Oyoshi, S. Kawamoto, H. C. Oettgen, and E. N. Tsitsikov TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45 Int. Immunol., January 1, 2006; 18(1): 101 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, Y.-H. Wang, O. Duramad, T. Hori, G. J. Delespesse, N. Watanabe, F. X.-F. Qin, Z. Yao, W. Cao, and Y.-J. Liu TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand J. Exp. Med., November 7, 2005; 202(9): 1213 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Akiyama, S. Maeda, S. Yamane, K. Ogino, M. Kasai, F. Kajiura, M. Matsumoto, and J.-i. Inoue Dependence of Self-Tolerance on TRAF6-Directed Development of Thymic Stroma Science, April 8, 2005; 308(5719): 248 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, M. Walsh, A. V. Villarino, L. Cervi, C. A. Hunter, Y. Choi, and E. J. Pearce TLR Ligands Can Activate Dendritic Cells to Provide a MyD88-Dependent Negative Signal for Th2 Cell Development J. Immunol., January 15, 2005; 174(2): 742 - 751. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |